Medical device manufacturer Medartis has lifted its financial guidance for 2026, supported by strong revenue growth and operational momentum reported in its first-half results.
The updated outlook reflects management's confidence in continued demand for the company's orthopedic and surgical solutions across its key markets. Further details regarding the revised targets and regional performance were discussed during the company's recent earnings call.
